Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.26) per share. This is a 4 percent decrease over losses of $(0.25) per share from the same period last year.
Citigroup Initiates Coverage On Plains All American with Buy Rating, Announces Price Target of $14
Citigroup analyst Spiro Dounis initiates coverage on Plains All American (NASDAQ:PAA) with a Buy rating and announces Price Target of $14.